BaseSpace
Correlation Engine 2.0
Import Your Data
Literature

FAQ

More FAQs

Back to top
Clear Search sequence regions
(e.g. Doxycycline, rs2476601, FABP1, cell-cell adhesion, Breast Cancer, Stem cell)
Bookmark Forward

New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam.

Frédéric J J Bihel, Hélène Justiniano, Martine Schmitt, Malik Hellal, Mohamed A Ibrahim, Claire Lugnier, Jean-Jacques Bourguignon

Laboratoire d'Innovation Thérapeutique, UMR 7200, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, 67400 Illkirch Graffenstaden, France. fbihel@unistra.fr

Bioorganic & medicinal chemistry letters 2011 Nov 1


filter terms:
  • benzodiazepines (2)
  • inhibitory concentration 50 (1)
  • papaverine (4)
  • pde4 inhibitors (1)
  • pde4 inhibitors (3)
  • phosphodiesterase 4 (1)
  • tofisopam (3)
    • Sizes of these terms reflect their relevance to your search.

    Pharmacophoric comparison between papaverine and tofisopam led to identify three new series of micro- to sub-micromolar inhibitors of phosphodiesterase-4, including 7,8-dialkoxy-2,3-benzodiazepin-4-one derivatives, 7,8-dialkoxy-1,4-benzodiazepin-2-one derivatives, and dialkoxybenzophenone derivatives. Copyright © 2011 Elsevier Ltd. All rights reserved.

    Citation

    Frédéric J J Bihel, Hélène Justiniano, Martine Schmitt, Malik Hellal, Mohamed A Ibrahim, Claire Lugnier, Jean-Jacques Bourguignon. New PDE4 inhibitors based on pharmacophoric similarity between papaverine and tofisopam. Bioorganic & medicinal chemistry letters. 2011 Nov 1;21(21):6567-72

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 21920746

    View Full Text
    • Copyright © 2021 Illumina Inc. All rights reserved.